Ryvu Therapeutics SA

Pologne

 
Quantité totale PI 42
Rang # Quantité totale PI 33 305
Note d'activité PI 2,4/5.0    33
Rang # Activité PI 23 278
Classe Nice dominante Produits chimiques destinés à l'...

Brevets

Marques

10 2
12 0
13 2
3
 
Dernier brevet 2025 - Modulators of the adenosine a2a ...
Premier brevet 2013 - Substituted tricyclic benzimidaz...
Dernière marque 2019 - RYVU THERAPEUTICS
Première marque 2019 - RYVU

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Prmt5 inhibitors. The present invention relates to compounds of formula (I) and salts, stereoisom...
2023 Invention Cancer combination therapy including a flt3-inhibitor. The present invention is inter alia concer...
Invention Cancer combination therapy including a bcl-2 inhibitor. The present invention is inter alia conce...
Invention Cancer combination therapy including a bcl-2 inhibitor
Invention Cancer combination therapy including a flt3-inhibitor
Invention Modulators of the adenosine a2a and a2b receptor. The present invention relates to the compound o...
2021 Invention Tetrazole derivatives. Substituted tetrazole derivatives are useful for the prevention and/or tr...
Invention Amide derivatives. Substituted amide derivatives are useful for the prevention and/or treatment ...
Invention Condensed pyridine derivastives substitued by amide functions as acss2 inhibitors. The present in...
Invention Tetrazole derivatives. The present invention relates to substituted tetrazole derivatives. These ...
2020 Invention Heterocyclic compounds as modulators of stimulator of interferon genes (sting). The present inve...
Invention Functionalized heterocyclic compounds as modulators of stimulator of interferon genes (sting). T...
Invention Heterocyclic compounds as modulators of stimulator of interferon genes (sting). The present inven...
Invention Functionalized heterocyclic compounds as modulators of stimulator of interferon genes (sting). Th...
Invention Thiophene derivatives. Compounds of the formula I Compounds of the formula I Compounds o...
Invention Condensed thiophene derivatives as hypoxia inducible factor (hif) inhibitors. Compounds of the fo...
Invention Next-generation modulators of stimulator of interferon genes (sting). The present invention rela...
Invention Next-generation modulators of stimulator of interferon genes (sting). The present invention relat...
2019 Invention Modulators of the adenosine a2a receptor. The present invention relates to the compounds of formu...
Invention Disubstituted alkyne derivatives. The present invention relates to disubstituted alkyne derivativ...
P/S Chemical preparations being additives for use in the manufacture of pharmaceuticals; chemical pre...
P/S Chemical preparations for use in the manufacture of pharmaceuticals; chemical preparations for s...
P/S Chemical preparations for use in the manufacture of pharmaceuticals; Chemical preparations for sc...
Invention Modulators of stimulator of interferon genes (sting). The present invention relates to compounds ...
Invention Thiophene derivatives. Compounds of the formula I 1 denotes a mono- or bicyclic aromatic, unsatu...
Invention Thiophene derivatives. Compounds of the formula (I) in which R1, R2, R3, R4 and n have the meanin...
2018 Invention Imidazo[1,2-a]pyrazine modulators of the adenosine a2a receptor. The present invention relates t...
Invention Imidazo[1,2-a]pyrazine modulators of the adenosine a2a receptor. The present invention relates to...
2016 Invention Benzimidazole derivatives as kinase inhibitors. The present invention relates to derivatives of b...
2013 Invention Novel benzimidazole derivatives as kinase inhibitors. The present invention relates to deri...
Invention Substituted tricyclic benzimidazoles as kinase inhibitors. Disclosed are substituted tricyc...